Navigation Links
Neurocrine Biosciences Reports Second Quarter 2013 Results
Date:7/25/2013

and report on Form 10-Q for the quarter ended March 31, 2013. Neurocrine undertakes no obligation to update the statements contained in this press release after the date hereof.NEUROCRINE BIOSCIENCES, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data) (unaudited) Three Months Ended
June 30,Six Months Ended
June 30,2013201220132012Revenues:Sponsored research and development 

$
-$
,540$
-$
3,569Milestones and license fees7309,0291,46018,267Total revenues73010,5691,46021,836Operating expenses:Research and development10,5278,81820,84018,206General and administrative3,3703,1316,7626,802Total operating expenses13,89711,94927,60225,008Loss from operations(13,167)(1,380)(26,142)(3,172)Other income:Gain on sale/disposal of assets19-3225Deferred gain on real estate7817591,5631,517Investment income, net121115224236Other income, net4567Total other income9258791,8251,785Net loss

$ (12,242)$
(501)$ (24,317)$  (1,387)Net loss per common share:Basic and diluted$
(0.18)$
(0.01)$
(0.36)$
(0.02)Shares used in the calculation of net loss per common share:Basic and diluted66,79966,30966,70064,857NEUROCRINE BIOSCIENCES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) (unaudited) June 30, 2013December 31,
2012Cash, cash equivalents and short-term marketable securities

$
53,696$
73,013Other current assets

2,15716,251Total current assets

155,853189,264Property and equipment, net

1,8761,900Long-term investments

12,749480Restricted cash

4,3354,335Total assets

$
74,813$
95,979Current liabilities

$
4,573$
5,646Long-term liabilities

24,22425,961Stockholders' equity

136,016154,372Total liabilities and stockholders' equity

$
74,813$
95,979 


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
2. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
3. Neurocrine Biosciences to Present at The 24th Annual Roth Conference
4. Neurocrine Biosciences Reports Second Quarter 2012 Results
5. Neurocrine Biosciences Reports Third Quarter 2012 Results
6. Neurocrine Biosciences To Present At The 24th Annual Piper Jaffray Healthcare Conference
7. Neurocrine Biosciences Reports Fourth Quarter And Year End 2012 Results
8. Neurocrine Biosciences To Present At The Bank of America Merrill Lynch 2013 Health Care Conference
9. Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2013 Financial Results
10. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
11. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 26, 2014 Space is ... exploration of space requires astronauts to maintain consistently high ... success, and prevent potential errors and accidents. Despite the ... known about how cognition is affected by prolonged spaceflight, ... Now, Penn Medicine researchers are poised to help ...
(Date:11/26/2014)... The ETC (Emerging Technology Centers) ... announced today that applications for AccelerateBaltimore™ (AB) 2015 ... you have a big idea?,” asked ETC’s President ... about it. AccelerateBaltimore helps you and your big ... 13 weeks.” Interested game changers with “big ...
(Date:11/26/2014)... November 25, 2014 SonaCare Medical, ... Ultrasound (HIFU) devices, recently participated in the American ... Mass 360° .” Key opinion leaders in urology ... related to small renal masses while attendees had ... ablative technologies in hands-on labs. Attendees at the ...
(Date:11/26/2014)... November 25, 2014 The Pittcon marketing ... official conference and exposition mobile app, ... download in the App Store for iOS and Android ... resource tool before, during and after the event. It ... on exhibiting companies, technical sessions, Conferee Networking sessions and ...
Breaking Biology Technology:Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 2Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 3Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 4AccelerateBaltimore Applications to Close in 6 Days 2AccelerateBaltimore Applications to Close in 6 Days 3SonaCare Medical Supports American Urology Association’s Small Renal Mass 360° Summit 2SonaCare Medical Supports American Urology Association’s Small Renal Mass 360° Summit 3Pittcon Releases 2015 Mobile App 2
... Ventures, a venture capital,firm specializing in life science ... firm as its fourth partner. Broderick brings more,than ... fund,management, and technology commercialization. Before coming to ... in Milwaukee, WI, where he served on its ...
... EDT, EDMONTON, BELLEVUE, WASHINGTON, Sept. 12 /PRNewswire-FirstCall/ ... (the "Company") today announced that,the Company,s Board of ... of incorporation from the federal jurisdiction of Canada ... of America through a plan of,arrangement. Under the ...
... Inc., a,biotechnology company translating the complexity of human ... its president and,CEO, Dr. Keith O. Elliston, has ... Summit in Arlington, Va., September 17-18. Dr. ... on,"Enhancing Development and Commercial Value Added in Care ...
Cached Biology Technology:Dan Broderick Joins Prolog Ventures as Partner 2Dan Broderick Joins Prolog Ventures as Partner 3Biomira Announces Plan to Reincorporate in the United States 2Biomira Announces Plan to Reincorporate in the United States 3Biomira Announces Plan to Reincorporate in the United States 4Biomira Announces Plan to Reincorporate in the United States 5Biomira Announces Plan to Reincorporate in the United States 6Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit 2
(Date:11/4/2014)... , November 4, 2014   ... market growth   Fuel3D , a developer ... a funding round totaling $6.4 million (£4 million). This funding ... secured earlier this year and paves the way for the ... The funding round was led by Chimera Partners ...
(Date:11/3/2014)... study published in this month,s Proceedings of ... of a recently discovered communication molecule of the body,s ... known to limit inflammation and the current study reports ... the ability of the immune system to recognize and ... IL-37,s effect on the immune system now allows us ...
(Date:11/2/2014)... NEW ORLEANS, LA (2 November 2014)—In support of a ... the Bill & Melinda Gates Foundation today announced an ... PATH Malaria Vaccine Initiative (MVI) in building new vaccines ... and help realize the "accelerating to zero" agenda. Such ... providing what could be called an "immunological bed net." ...
Breaking Biology News(10 mins):Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3PNAS: From HIV to cancer, IL-37 regulates immune system 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 3New malaria vaccines to prevent infection and block transmission get a shot in the arm 4
... LOUIS - Researchers at the Saint Louis University School ... causes Parkinsons disease a breakthrough finding that could ... to treat one of the most common and debilitating ... Parkinsons disease, which afflicts more than 1.5 million Americans, ...
... Institute will host its third annual Ocean Future Symposium, ... 12 p.m., in the Woodrow Wilson auditorium. The symposium, ... Communities for Action," will envision a future where media ... to increase the general publics coastal and ocean literacy. ...
... of amphibians have been discovered in 330 million-year-old rocks ... and bodies of three previously unknown, foot-long salamander-like critters ... "Body impressions like this are wholly ... the New Mexico Museum of Natural History and Science. ...
Cached Biology News:St. Louis University scientists identify chemical that triggers Parkinson's disease 2Abel to receive posthumous Ocean and Coastal Leadership award 2Ancient amphibians left full-body imprints 2
GLP-compliant, CLIA-certified DNA sequencing service. ASQ and SQA certified quality assurance staff. Auditors welcome....
Sequencing and primer design rolled into one. Just give us your clone and a reference sequence, and we'll do the rest. Single-strand or double-strand coverage. Guaranteed results....
... to human XAB2 (amino terminus) XAB2 ... its interaction with XPA. Immunoprecipitation experiments have ... interacts with the transcription-coupled repair-specific proteins CSA ... polymerase II. Microinjection experiments with XAB2 antibodies ...
... using advanced automated high throughput microplate processing equipment that dispenses ... accommodate virtually any lot size of the following formats (with ... 8 and 12 well strips, ... 384 well microplate, 1536 ...
Biology Products: